Vsee Health, Inc.
VSEE· OTC
Filed Aug 21, 2023 · 10-Q · 52 days after period end · 0001104659-23-093992
| Metric | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|
| Revenue | $1.27M | — | — |
| Net Income | -$503.32K | -$659.46K | -$5.00K |
| EPS Diluted | -$0.11 | -$0.04 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vsee Health, Inc. · CIK 1864531 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Aug 21, 2023 · 52 d after period end